ACAD
USDACADIA Pharmaceuticals Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$21.940
High
$22.240
Low
$21.760
Volume
2.09M
Company Fundamentals
Market Cap
3.7B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.21M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) today announced that on July 2, 2025, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock
Oppenheimer Maintains Perform on ACADIA Pharmaceuticals, Raises Price Target to $22
Oppenheimer analyst Jay Olson maintains ACADIA Pharmaceuticals with a Perform and raises the price target from $19 to $22.
HC Wainwright & Co. Reiterates Buy on ACADIA Pharmaceuticals, Maintains $32 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates ACADIA Pharmaceuticals with a Buy and maintains $32 price target.
Needham Reiterates Buy on ACADIA Pharmaceuticals, Maintains $30 Price Target
Needham analyst Ami Fadia reiterates ACADIA Pharmaceuticals with a Buy and maintains $30 price target.
Acadia Pharmaceuticals Hosts Inaugural R&D Day Showcasing Pipeline and Long-Term Value Drivers
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) will host its inaugural 2025 R&D Day today to highlight its key pipeline programs and their potential to drive long-term growth. Across nine disclosed programs, the
RBC Capital Maintains Outperform on ACADIA Pharmaceuticals, Raises Price Target to $38
RBC Capital analyst Brian Abrahams maintains ACADIA Pharmaceuticals with a Outperform and raises the price target from $26 to $38.
Related Stocks
ACHL
Achilles Therapeutics plc American Depositary Shares
GHSI
Guardion Health Sciences Inc.
LMT
Lockheed Martin Corporation
RWAYZ
Runway Growth Finance Corp. 8.00% Notes due 2027
JBL
Jabil Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.